Wells Fargo & Company »

Unicycive Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $104k 22k 4.69

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Unicycive Therapeutics

BlackRock
Nantahala Capital Management
Diadema Partners
Vanguard Capital Management
Octagon Capital Advisors
Susquehanna International
Geode Capital Management
Vivo Capital
Marshall Wace
Caption Management
Logos Global Management
Diametric Capital
J. Goldman & Co
Citadel Advisors
Millennium Management

View all funds holding Unicycive Therapeutics